Novo Nordisk (NVO)
44.28
+0.61 +1.40%
NYSE
Jun 23, 11:25
Delayed 2m
USD
View All Key Stats
NVO Key Stats
| Income Statement | |
| Revenue (TTM) | 16.66B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.259 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.700B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 85.06% |
| Profit Margin (Quarterly) | 35.70% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.52% |
| Price and Valuation | |
| Market Cap | 112.91B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.703 |
| PE Ratio (TTM) | 19.60 |
| Price to Book Value | 19.50 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0152 |
| Free Cash Flow (Quarterly) | 1.488B |
| Return on Equity (TTM) | 93.49% |
View All NVO News
NVO News
-
WireHeadlineTime (ET)
-
Yahoo06/23 09:57
-
MT Newswires06/23 09:40
-
Yahoo06/23 07:42
-
MT Newswires06/23 07:29
-
Yahoo06/22 10:57
-
Yahoo06/21 11:17
-
SA Breaking News06/20 16:55
-
Yahoo06/20 14:39
-
Yahoo06/19 15:50
-
PR Newswire06/19 08:22
View All Events
NVO Events
| Date | Type | Description |
|---|---|---|
| 08/09/2017 | Earnings | Novo Nordisk A/S Second Quarter Earnings Results in 2017 |
| 05/03/2017 | Earnings | Novo Nordisk A/S First Quarter Earnings Results in 2017 |
| 03/23/2017 | Dividends | Amount: 0.6633, Declared Date: Feb 26 2017, Pay Date: Apr 04 2017 |
| 02/02/2017 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2016 |
| 10/28/2016 | Earnings | Novo-Nordisk A/S Third Quarter Earnings Results in 2016 |
| 08/11/2016 | Dividends | Amount: 0.4535, Declared Date: Aug 05 2016, Pay Date: Aug 23 2016 |
NVO Fundamentals
Income Statement View Statement
NVO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NVO One Page Reports
- One Page Report Download
NVO Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 44.28 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: Aug. 09, 2017
- Last Earnings Release: May. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 23, 2017
- Description: Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.
NVO Comparables
EditNVO Excel Add-In Codes
- Name: =YCI("NVO","name")
- Description: =YCI("NVO","description")
- Sector: =YCI("NVO","sector")
- Industry: =YCI("NVO","industry")
- Est. Current Fiscal Year End: =YCI("NVO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NVO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
